350 related articles for article (PubMed ID: 18258318)
1. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy.
Theodoropoulos TA; Bestetti RB; Otaviano AP; Cordeiro JA; Rodrigues VC; Silva AC
Int J Cardiol; 2008 Aug; 128(1):22-9. PubMed ID: 18258318
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study.
Salles G; Xavier S; Sousa A; Hasslocher-Moreno A; Cardoso C
Circulation; 2003 Jul; 108(3):305-12. PubMed ID: 12835217
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of anemia in patients with chronic systolic heart failure secondary to Chagas' cardiomyopathy.
Miguel CE; Bortoluzzi TB; Otaviano AP; Cardinalli-Neto A; Rocha BF; Ferrari SJ; Bestetti RB
Acta Trop; 2011 Dec; 120(3):219-23. PubMed ID: 21906579
[TBL] [Abstract][Full Text] [Related]
4. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy.
Nunes Mdo C; Rocha MO; Ribeiro AL; Colosimo EA; Rezende RA; Carmo GA; Barbosa MM
Int J Cardiol; 2008 Jul; 127(3):372-9. PubMed ID: 17689706
[TBL] [Abstract][Full Text] [Related]
5. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
6. Predictors of all-cause mortality for patients with Chagas' cardiomyopathy listed for heart transplantation.
Dib JA; Bestetti RB; Freitas PF; Theodoropoulos TA; Cardinalli-Neto A; Cordeiro JA
Int J Cardiol; 2009 Aug; 136(2):162-4. PubMed ID: 18649959
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.
Passino C; Pingitore A; Landi P; Fontana M; Zyw L; Clerico A; Emdin M; Iervasi G
J Card Fail; 2009 Feb; 15(1):35-40. PubMed ID: 19181292
[TBL] [Abstract][Full Text] [Related]
8. Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure.
Bestetti RB; Otaviano AP; Cardinalli-Neto A; da Rocha BF; Theodoropoulos TA; Cordeiro JA
Int J Cardiol; 2011 Sep; 151(2):205-8. PubMed ID: 20591516
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of formulas estimating excretory renal function in the elderly with systolic heart failure.
Scrutinio D; Passantino A; Santoro D; Cacciapaglia E; Farinola G
Age Ageing; 2009 May; 38(3):296-301. PubMed ID: 19252204
[TBL] [Abstract][Full Text] [Related]
10. Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy.
di Toro D; Muratore C; Aguinaga L; Batista L; Malan A; Greco O; Benchetrit C; Duque M; Baranchuk A; Maloney J
Pacing Clin Electrophysiol; 2011 Sep; 34(9):1063-9. PubMed ID: 21535031
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.
Freitas HF; Chizzola PR; Paes AT; Lima AC; Mansur AJ
Int J Cardiol; 2005 Jul; 102(2):239-47. PubMed ID: 15982491
[TBL] [Abstract][Full Text] [Related]
12. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
Cardinalli-Neto A; Bestetti RB; Cordeiro JA; Rodrigues VC
J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1236-40. PubMed ID: 17900257
[TBL] [Abstract][Full Text] [Related]
13. Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]).
Domanski M; Coady S; Fleg J; Tian X; Sachdev V
Am J Cardiol; 2007 May; 99(10):1448-50. PubMed ID: 17493477
[TBL] [Abstract][Full Text] [Related]
14. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
Güder G; Bauersachs J; Frantz S; Weismann D; Allolio B; Ertl G; Angermann CE; Störk S
Circulation; 2007 Apr; 115(13):1754-61. PubMed ID: 17372171
[TBL] [Abstract][Full Text] [Related]
15. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.
Uretsky BF; Thygesen K; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L; Cleland JG
J Card Fail; 2008 Oct; 14(8):670-5. PubMed ID: 18926439
[TBL] [Abstract][Full Text] [Related]
16. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.
Güder G; Frantz S; Bauersachs J; Allolio B; Wanner C; Koller MT; Ertl G; Angermann CE; Störk S
Circ Heart Fail; 2009 Nov; 2(6):563-71. PubMed ID: 19919981
[TBL] [Abstract][Full Text] [Related]
17. Sex-based differences in the effect of digoxin for the treatment of heart failure.
Rathore SS; Wang Y; Krumholz HM
N Engl J Med; 2002 Oct; 347(18):1403-11. PubMed ID: 12409542
[TBL] [Abstract][Full Text] [Related]
18. Predictors of outcome in patients with suspected myocarditis.
Kindermann I; Kindermann M; Kandolf R; Klingel K; Bültmann B; Müller T; Lindinger A; Böhm M
Circulation; 2008 Aug; 118(6):639-48. PubMed ID: 18645053
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of Chagas' disease in patients awaiting heart transplantation.
Bertolino ND; Villafanha DF; Cardinalli-Neto A; Cordeiro JA; Arcanjo MJ; Theodoropoulos TA; Bestetti RB
J Heart Lung Transplant; 2010 Apr; 29(4):449-53. PubMed ID: 20006935
[TBL] [Abstract][Full Text] [Related]
20. QT interval dispersion in patients with chronic heart failure secondary to Chagas' cardiomyopathy: correlation with clinical variables of prognostic significance.
Corbucci HA; Haber DM; Bestetti RB; Cordeiro JA; Fioroni ML
Cardiovasc Pathol; 2006; 15(1):18-23. PubMed ID: 16414452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
